Calfactant Completed Phase 3 Trials for Chronic Lung Disease of Prematurity / Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction) Treatment

Indications	Status	Purpose	Phase
DBCOND0044076 (Chronic Lung Disease of Prematurity) DBCOND0087363 (Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction))	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT00569530	Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide	Calfactant (DB06415)